Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Plos One|January 25, 2024
Differential laboratory passaging of SARS-CoV-2 viral stocks impacts the in vitro assessment of neutralizing antibodiesAram Avila-Herrera, Jeffrey A Kimbrel, Jose Manuel Martí, et al.
Scientific Reports|November 16, 2017
Timescale Separation of Positive and Negative Signaling Creates History-Dependent Responses to IgE Receptor StimulationBrooke Harmon, Lily A Chylek, Yanli Liu, et al.
Eukaryotic Cell|May 20, 2014
Trypanosoma brucei translation initiation factor homolog EIF4E6 forms a tripartite cytosolic complex with EIF4G5 and a capping enzyme homologEden R Freire, Amaranta M Malvezzi, Ajay A Vashisht, et al.
RNA (New York, N.Y.)|June 26, 2014
eIF4F-like complexes formed by cap-binding homolog TbEIF4E5 with TbEIF4G1 or TbEIF4G2 are implicated in post-transcriptional regulation in Trypanosoma bruceiEden R Freire, Ajay A Vashisht, Amaranta M Malvezzi, et al.
Scientific Reports|April 27, 2023
Lipid-coated mesoporous silica nanoparticles for anti-viral applications via delivery of CRISPR-Cas9 ribonucleoproteinsAnnette E LaBauve, Edwin A Saada, Iris K A Jones, et al.
Acta Biomaterialia|July 24, 2020
Engineering of monosized lipid-coated mesoporous silica nanoparticles for CRISPR deliveryAchraf Noureddine, Angelea Maestas-Olguin, Edwin A Saada, et al.
Mabs|August 4, 2021
Development of potent and effective synthetic SARS-CoV-2 neutralizing nanobodiesMaxwell A Stefan, Yooli K Light, Jennifer L Schwedler, et al.
Frontiers in Molecular Biosciences|July 30, 2021
Discovery of Small-Molecule Inhibitors of SARS-CoV-2 Proteins Using a Computational and Experimental PipelineEdmond Y Lau, Oscar A Negrete, W F Drew Bennett, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2022
Computationally restoring the potency of a clinical antibody against SARS-CoV-2 Omicron subvariantsThomas A Desautels, Kathryn T Arrildt, Adam T Zemla, et al.
Nature|May 8, 2024
Computationally restoring the potency of a clinical antibody against OmicronThomas A Desautels, Kathryn T Arrildt, Adam T Zemla, et al.
Pageof 2